Patients’ characteristics
| Diabetes | Non-diabetes | p Value | |
|---|---|---|---|
| Number of patients, n (%) | 53 (23.2%) | 175 (76.8%) | |
| Age, year | 68±10 | 65±12 | 0.09 |
| Gender, male/female | 31/22 | 89/86 | 0.35 |
| Height, cm | 158.1±9.5 | 159.5±9.7 | 0.35 |
| Weight, kg | 62.9±12.8 | 62.1±11.3 | 0.64 |
| Body mass index | 25.0±3.3 | 24.3±3.3 | 0.20 |
| Dyslipidaemia, n (%) | 30 (56.6) | 76 (43.4) | 0.12 |
| Smoker, n (%) | 13 (24.5) | 61 (34.9) | 0.18 |
| History of myocardial infarction, n (%) | 2 (3.8) | 7 (4.0) | 0.99 |
| Angina pectoris, n (%) | 7 (13.2) | 27 (15.4) | 0.83 |
| Myocardial infarction+angina, n (%) | 8 (15.1) | 31 (17.7) | 0.84 |
| History of stroke, n (%) | 3 (5.7) | 10 (5.7) | 0.99 |
| Medications | |||
| Amlodipine, n (%) | 14 (26.4) | 58 (33.1) | 0.40 |
| Renin-angiotensin-aldosterone system inhibitors, n (%) | 28 (52.8) | 78 (44.6) | 0.35 |
| β-blockers, n (%) | 8 (15.6) | 26 (14.7) | 0.99 |
| Diuretics, n (%) | 4 (7.5) | 10 (5.7) | 0.74 |
| Statins, n (%) | 24 (45.3) | 49 (28.0) | 0.03 |
| Fasting blood glucose, mg/dL | 139±37 | 99±11 | <0.0001 |
| HbA1c, % | 6.9±0.7 | 5.7±0.3 | <0.0001 |
| Total cholesterol, mg/dL | 198±35 | 207±31 | 0.08 |
| Low-density lipoprotein cholesterol, mg/dL | 115±35 | 120±30 | 0.38 |
| High-density lipoprotein cholesterol, mg/dL | 50±13 | 56±16 | 0.01 |
| Triglyceride, mg/dL | 163±87 | 158±109 | 0.76 |
| Serum creatinine, mg/dL | 0.90±0.48 | 0.88±0.63 | 0.88 |
| Estimated glomerular filtration rate, mL/min/1.73 m2 | 61.4±15.5 | 63.2±16.3 | 0.50 |
| Brain natriuretic peptide, pg/dL | 33.4±40.5 | 39.3±66.7 | 0.56 |
| High sensitive C reactive protein, mg/dL | 1.60±2.60 | 1.71±2.48 | 0.79 |
Each value depicts mean±SD or number of patients (%).
HbA1c, glycosylated haemoglobin.